Randomized trial Frontiers in cellular and infection microbiology · 2026 Gut microbial dynamics and antibiotic resistance during rifaximin therapy in severe cirrhosis: a ProPILA-Rifax ancillary study. Ladeira R, Biguenet A, Meunier A, et al. Blautia obeumEscherichia coliRuminococcus bromiiVeillonella PubMed ↗
Observational Clinical and translational gastroenterology · 2026 Alterations in the Gut Microbiota of Cirrhotic Patients With Sarcopenia and PH After TIPS. Wang H, Cao Y, Zhang X, et al. ButyricimonasFaecalibacteriumFusicatenibacterIntestinibacter +3 more PubMed ↗
Randomized trial Alimentary pharmacology & therapeutics · 2026 Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial. Inada H, Toyota T, Uojima H, et al. Eubacterium PubMed ↗
Review The lancet. Gastroenterology & hepatology · 2026 Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship. Jalan R, Patel VC, Shoaie S Enterococcus faecium PubMed ↗
Observational Journal of gastroenterology and hepatology · 2026 Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort. Jinato T, Sikaroodia M, Gilleveta PM, et al. Mediterraneibacter gnavusCoprococcusSubdoligranulum PubMed ↗
Randomized trial Canadian journal of gastroenterology & hepatology · 2026 Rifaximin Plus Probiotics Reshape Gut Microbiota, Serum Propionate, and Mucosal Immunity in Cirrhosis-Related Hepatic Encephalopathy Microbiota-Immune Remodeling in HE. Wang Y, Zhu H, Wang S, et al. Bacteroides ovatusLigilactobacillus salivarius PubMed ↗
Observational Journal of translational medicine · 2025 Intestinal congestion-driven gut dysbiosis: a cross-disease hemodynamic mechanism in liver cirrhosis and heart failure. Wang Y, Bai Z, Sun J, et al. CoprococcusVeillonella PubMed ↗
Observational Scientific reports · 2025 Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma. Marawan AE, Elmetwally OA, Marwan MM, et al. Fusobacterium PubMed ↗
Randomized trial Liver international · 2025 A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention. Vega-Abellaneda S, Román E, Soler Z, et al. Akkermansia muciniphilaLactobacillus acidophilusStreptococcus thermophilusBacteroides +1 more PubMed ↗
Observational Clinical and translational gastroenterology · 2025 Fecal Microbiota and Bile Acid Profiles in Early-Stage Hepatocellular Carcinoma: A Matched Case-Control Study. Nobel YR, Park H, Tillman AM, et al. Klebsiella pneumoniae PubMed ↗
Observational Clinical nutrition · 2025 An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study. Habich D, Horvath A, Feldbacher N, et al. EnterococcusFlavonifractorRomboutsia PubMed ↗
Observational Frontiers in immunology · 2025 Featured intestinal microbiota associated with hepatocellular carcinoma in various liver disease states. Sun X, Zhou Z, Chi X, et al. FaecalibacteriumHaemophilusMegasphaeraParaprevotella +4 more PubMed ↗
Randomized trial Liver international · 2025 Probiotics Prevent Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomised Controlled Trial. Quan X, Li Y, Ye X, et al. Bifidobacterium PubMed ↗
Observational BMC gastroenterology · 2025 Relationship between gut microbiota dysbiosis and bile acid in patients with hepatitis B-induced cirrhosis. Li Y, Zhang D, Tian T, et al. Veillonella PubMed ↗
Observational Hepatology · 2025 Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multicenter cirrhosis outpatient cohort. Bajaj JS, Reddy KR, Tandon P, et al. HaemophilusPrevotellaStreptococcusVeillonella PubMed ↗
Clinical trial The American journal of gastroenterology · 2025 Microbial Dysbiosis in the Urinary Microbiome of Patients With Cirrhosis. Woltsche J, Pacher-Deutsch C, Fürst S, et al. Streptococcus PubMed ↗
Observational Frontiers in cellular and infection microbiology · 2025 Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression. Shi K, Sun L, Feng Y, et al. AlistipesEnterococcusFusobacteriumLachnospira PubMed ↗
Observational mSphere · 2025 Small amounts of misassembly can have disproportionate effects on pangenome-based metagenomic analyses. Majernik SN, Beaver L, Bradley PH Lachnospira eligensHaemophilusVeillonella PubMed ↗
Observational Scientific reports · 2025 Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis. Gulyaeva K, Nadinskaia M, Maslennikov R, et al. EnterococcusEscherichiaFaecalibacteriumGemmiger +3 more PubMed ↗
Meta-analysis BMC gastroenterology · 2025 Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis. Liu Y, Chen Z, Li C, et al. HaemophilusStreptococcusVeillonella PubMed ↗